DB16978InvestigationalProtein Based Therapies
Latozinemab: Overview.
- Also known as
- AL001 · GSK4527223
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Latozinemab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account